Grenoble, France

Richard Ammer

This inventor holds 1 USPTO granted patent. Top assignee: Probiogen Ag. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Ammer. Retrieved from https://idiyas.com/inventor/richard-ammer-d9cueacj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Invention and Impact of Richard Ammer in Immunogenicity Testing

Introduction

Richard Ammer is an esteemed inventor based in Grenoble, France, recognized for his innovative contributions to the field of immunology. With one patent to his name, Richard focuses on advancing methods that enhance the testing of immune cells and their functions.

Latest Patents

Richard's notable patent is titled "Culture system and method for immunogenicity and immunofunction testing in vitro." This invention introduces a sophisticated culture device comprising several culture units. Each unit features a culture chamber, an inlet port for the liquid supply, and an outlet port for discharging liquid. The design allows for efficient liquid flow through the culture chamber, enabling enhanced testing of immune cells and their immunofunction in vitro. This invention is particularly beneficial for analyzing the effects of various test compounds on immune cell responses.

Career Highlights

Richard Ammer is affiliated with Probiogen AG, where he applies his expertise in immunology. His experience and knowledge contribute significantly to the organization's research and development efforts, creating valuable solutions in the realm of immunogenicity and cell testing.

Collaborations

Throughout his career, Richard has worked alongside notable colleagues, including Christian Demmler and Uwe Marx. Their joint efforts have fostered a collaborative environment that encourages innovation and the successful development of groundbreaking inventions in their field.

Conclusion

Richard Ammer's dedication to enhancing immunogenicity testing through his patent demonstrates his commitment to innovation. His work at Probiogen AG, combined with collaborative efforts with esteemed coworkers, positions him as a prominent figure in the advancement of immunological methodologies. These contributions not only benefit the scientific community but also have the potential to impact healthcare practices significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…